Compare FBIN & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBIN | SHC |
|---|---|---|
| Founded | 1988 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.2B |
| IPO Year | 2011 | 2020 |
| Metric | FBIN | SHC |
|---|---|---|
| Price | $48.28 | $15.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 10 |
| Target Price | ★ $49.47 | $21.94 |
| AVG Volume (30 Days) | ★ 2.5M | 2.4M |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | 0.43 | ★ 0.48 |
| Revenue | ★ $4,463,200,000.00 | $1,163,617,000.00 |
| Revenue This Year | N/A | $7.02 |
| Revenue Next Year | $0.51 | $5.71 |
| P/E Ratio | $110.40 | ★ $34.15 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $32.34 | $13.09 |
| 52 Week High | $64.84 | $19.85 |
| Indicator | FBIN | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 72.23 | 28.73 |
| Support Level | $47.92 | $14.93 |
| Resistance Level | $54.39 | $16.41 |
| Average True Range (ATR) | 2.03 | 0.60 |
| MACD | 0.64 | -0.26 |
| Stochastic Oscillator | 83.67 | 4.83 |
Fortune Brands is a US-based homebuilding products company that sells building-related products serving R&R and new construction markets. The company operates in three segments: water, outdoors, and security. Water innovation, including plumbing fixtures and faucets, accounts for around 55% of total sales and features brands such as Moen, House of Rohl, and Aqualisa. The outdoors segment includes decking, railing, and doors and makes up 30% of total sales, featuring brands such as Larson, Fiberon, and Therma-Tru. The security segment, which includes smart residential padlocks, accounts for the remaining 15% of sales and features brands such as MasterLock, SentrySafe, Yale, and AmericanLock.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.